BORATR Balance Sheet Health
Financial Health criteria checks 5/6
BORATR has a total shareholder equity of ₩83.9B and total debt of ₩9.0B, which brings its debt-to-equity ratio to 10.8%. Its total assets and total liabilities are ₩104.1B and ₩20.2B respectively. BORATR's EBIT is ₩13.1B making its interest coverage ratio -15.2. It has cash and short-term investments of ₩32.8B.
Key information
10.8%
Debt to equity ratio
₩9.04b
Debt
Interest coverage ratio | -15.2x |
Cash | ₩32.77b |
Equity | ₩83.90b |
Total liabilities | ₩20.24b |
Total assets | ₩104.15b |
Recent financial health updates
BORATR (KOSDAQ:250000) Seems To Use Debt Quite Sensibly
Apr 14These 4 Measures Indicate That BORATR (KOSDAQ:250000) Is Using Debt Reasonably Well
Jan 12Recent updates
BORATR (KOSDAQ:250000) Seems To Use Debt Quite Sensibly
Apr 14The BORATR (KOSDAQ:250000) Share Price Is Up 42% And Shareholders Are Holding On
Mar 02Is BORATR (KOSDAQ:250000) Using Capital Effectively?
Feb 11Should BORATR CO., Ltd. (KOSDAQ:250000) Be Part Of Your Income Portfolio?
Jan 27These 4 Measures Indicate That BORATR (KOSDAQ:250000) Is Using Debt Reasonably Well
Jan 12Are BORATR's (KOSDAQ:250000) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 27BORATR CO., Ltd. (KOSDAQ:250000) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Dec 11BORATR's (KOSDAQ:250000) Stock Price Has Reduced 15% In The Past Three Years
Nov 26Financial Position Analysis
Short Term Liabilities: A250000's short term assets (₩64.7B) exceed its short term liabilities (₩19.9B).
Long Term Liabilities: A250000's short term assets (₩64.7B) exceed its long term liabilities (₩347.9M).
Debt to Equity History and Analysis
Debt Level: A250000 has more cash than its total debt.
Reducing Debt: A250000's debt to equity ratio has increased from 4.3% to 10.8% over the past 5 years.
Debt Coverage: A250000's debt is well covered by operating cash flow (89.8%).
Interest Coverage: A250000 earns more interest than it pays, so coverage of interest payments is not a concern.